Related Experiment Video
Updated: Sep 28, 2025

Patch Angioplasty in the Rat Aorta or Inferior Vena Cava
Published on: February 27, 2017
Patch Pumps: What are the advantages for people with diabetes?
Bernhard Kulzer1, Guido Freckmann2, Lutz Heinemann3
1Research Institute of the Diabetes-Academy Mergentheim, Bad Mergentheim, Germany; Diabetes Center Mergentheim, Bad Mergentheim, Germany; University Bamberg, Bamberg, Germany.
Patch pumps offer advantages for diabetes management, improving quality of life and patient satisfaction compared to traditional methods. Further research is needed to fully understand their benefits for patient-reported outcomes.
Area of Science:
- Diabetes Technology
- Endocrinology
- Patient-Reported Outcomes
Background:
- Tubeless patch pumps are an emerging alternative to conventional insulin pumps for individuals with type 1 and type 2 diabetes.
- Patient-reported outcomes (PROs) are crucial for evaluating the real-world impact of diabetes management devices.
Purpose of the Study:
- To review potential patient-relevant advantages and disadvantages of patch pumps.
- To assess existing studies on patient-reported outcomes associated with patch pump use.
Main Methods:
- Systematic PubMed search and reference list checking were employed.
- Included English-language articles published before June 30, 2021.
Main Results:
- Patch pumps demonstrated improvements in quality of life, reduced diabetes-related distress, and increased patient satisfaction.
- Patients expressed a preference for patch pumps over conventional insulin pumps and multiple daily injections (MDI).
- Methodological limitations in the reviewed studies were noted.
Conclusions:
- Evidence suggests a patient preference for patch pumps, despite limited studies on PROs.
- The understudied nature of PROs for patch pumps is highlighted.
- Further systematic evaluation of patch pump benefits on PROs is recommended.
Related Concept Videos
Hemodialysis I: Introduction
Peripheral Artery Disease V: Postoperative Nursing Management
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Peritoneal Dialysis I: Introduction and Procedure
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

